Jayda Greco works at the intersection of healthcare regulatory, privacy and compliance, product counseling and marketing law, with particular emphasis on digital health products and services. Often working cross-functionally with stakeholders in sales, finance, marketing and product, Jayda is adept at devising creative and practical legal solutions for digital health initiatives to meet business objectives.
Jayda has a solid background in product development and the protection of intellectual property, gained from her years as in-house counsel for a national virtual care company, where she advised cross-functional groups of product managers and engineers on the creation and implementation of new features and functionality within iOS, Android and web platforms, as well as the risks and liabilities of proposed commercial models and transactions. She has a keen understanding of the Federal Trade Commission (FTC) Act, trademark, copyright and state consumer protection and marketing laws related to medical services and pharmaceuticals. She provides guidance on collateral and social media influencer campaigns, as well as drafting internal guidance and training on key issues to help her client maximize their marketing success while remaining in compliance with the complex healthcare and life sciences marketing and advertising regulations.
Jayda advises healthcare clients on compliance with HIPAA, CCPA as well as state and data breach laws where they converge with corporate transactions. She is a Certified Information Privacy Professional/United States (CIPP/US). Jayda also evaluates new business opportunities for her clients, examining health regulatory, privacy implications and similar concerns within the healthcare and consumer technology landscape at the federal and state level.
- International Association of Privacy Professionals (IAPP), Member
- University of Washington, JD
- University of Washington, BA
- Illinois
- Washington
Webinar / Virtual / April 15, 2026
Peptides Under the Microscope: Regulation, Enforcement, and Market Implications
Article / February 25, 2026
FDA’s Makary declares upcoming crackdown on GLP-1 claims, importation
Article / January 28, 2026
Telehealth flexibilities set to expire January 30, with two-year extension proposed: What you ...
Client alert / January 7, 2026
GLP-1 coverage expansion under Medicare: What digital health companies need to know
Article / December 29, 2025
New Illinois law provides coverage for HRT care for menopause
Client alert / December 30, 2025
DEA extends telemedicine flexibilities for controlled substance prescribing for 2026
Article / February 25, 2026
FDA’s Makary declares upcoming crackdown on GLP-1 claims, importation
Article / January 28, 2026
Telehealth flexibilities set to expire January 30, with two-year extension proposed: What you ...
Client alert / January 7, 2026
GLP-1 coverage expansion under Medicare: What digital health companies need to know
Article / December 29, 2025
New Illinois law provides coverage for HRT care for menopause
Client alert / December 30, 2025
DEA extends telemedicine flexibilities for controlled substance prescribing for 2026
Article / November 18, 2025
Connecticut bans mandatory electronic payment info for healthcare access
Webinar / Virtual / April 15, 2026
Peptides Under the Microscope: Regulation, Enforcement, and Market Implications
Webinar / Virtual / October 1, 2025
Key Takeaways | The GLP-1 Effect: Innovative Care Delivery Models and Compliant Disease ...
Webinar / Speaking engagement / July 24, 2025
Webinar / Virtual / March 13, 2025
Key Takeaways | Federal and State Policy Impacting Innovative Care Delivery Models
Webinar / Virtual / March 13 – April 24, 2025
Virtual / Speaking engagement / November 4, 2024
DEI in Healthcare: Turning a Heavy Topic into a Manageable Lift
Chicago / Political Hope / August 21, 2025
Press release / October 31, 2024
Employee Relations Law Journal / September 21, 2022
Disclaimer
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.